Helicobacter pylori infection and exaggerated gastrin release: Effects of inflammation and progastrin processing

D. Y. Graham, M. F. Go, G. M. Lew, R. M. Genta, J. F. Rehfeld

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Helicobacter pylori infection is associated with exaggerated gastrin release. We investigated whether this abnormality was due to the bacteria or the immune response. Fasting and meal-stimulated 'total' and amidated gastrin were measured in 10 H. pylori-infected volunteers before eradication therapy, after 2 and 14 days of therapy, and 4 weeks after completion of therapy. The exaggerated meal-stimulated gastrin concentration remained unchanged after 2 days of therapy, although the polymorphonuclear cell infiltrate and H. pylori bacteria were no longer evident. The expected fall in gastrin concentration after 14 days of therapy was associated with a reduction in the density of mucosal mononuclear cells, suggesting exaggerated gastrin release was related to chronic inflammation or to H. pylori or its products. The effect of H. pylori on normal progastrin processing was also assessed; 2 control groups were included: 10 H. pylori-uninfected volunteers and 13 patients with H. pylori peptic ulcers. There was a significant difference in the proportion of circulating gastrins that were biologically active amidated gastrins between ulcer patients and uninfected controls (56.7 ± 4% versus 33.8 ± 4% p < 0.001). The proportion of amidated to total gastrins did not increase after successful eradication.

Original languageEnglish (US)
Pages (from-to)690-694
Number of pages5
JournalScandinavian Journal of Gastroenterology
Volume28
Issue number8
DOIs
StatePublished - 1993

Fingerprint

Gastrins
Helicobacter Infections
Helicobacter pylori
Inflammation
Meals
Volunteers
Bacteria
Therapeutics
big gastrin
Peptic Ulcer
Ulcer
Fasting
Control Groups

Keywords

  • Ammonium
  • Biopsy
  • Clinical trial
  • Gastrin
  • Gastrin processing
  • Helicobacter pylori
  • Progastrin
  • Regulation
  • Triple therapy
  • Urea

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Helicobacter pylori infection and exaggerated gastrin release : Effects of inflammation and progastrin processing. / Graham, D. Y.; Go, M. F.; Lew, G. M.; Genta, R. M.; Rehfeld, J. F.

In: Scandinavian Journal of Gastroenterology, Vol. 28, No. 8, 1993, p. 690-694.

Research output: Contribution to journalArticle

Graham, D. Y. ; Go, M. F. ; Lew, G. M. ; Genta, R. M. ; Rehfeld, J. F. / Helicobacter pylori infection and exaggerated gastrin release : Effects of inflammation and progastrin processing. In: Scandinavian Journal of Gastroenterology. 1993 ; Vol. 28, No. 8. pp. 690-694.
@article{70710720580e413a9c7c66a4d5d488cf,
title = "Helicobacter pylori infection and exaggerated gastrin release: Effects of inflammation and progastrin processing",
abstract = "Helicobacter pylori infection is associated with exaggerated gastrin release. We investigated whether this abnormality was due to the bacteria or the immune response. Fasting and meal-stimulated 'total' and amidated gastrin were measured in 10 H. pylori-infected volunteers before eradication therapy, after 2 and 14 days of therapy, and 4 weeks after completion of therapy. The exaggerated meal-stimulated gastrin concentration remained unchanged after 2 days of therapy, although the polymorphonuclear cell infiltrate and H. pylori bacteria were no longer evident. The expected fall in gastrin concentration after 14 days of therapy was associated with a reduction in the density of mucosal mononuclear cells, suggesting exaggerated gastrin release was related to chronic inflammation or to H. pylori or its products. The effect of H. pylori on normal progastrin processing was also assessed; 2 control groups were included: 10 H. pylori-uninfected volunteers and 13 patients with H. pylori peptic ulcers. There was a significant difference in the proportion of circulating gastrins that were biologically active amidated gastrins between ulcer patients and uninfected controls (56.7 ± 4{\%} versus 33.8 ± 4{\%} p < 0.001). The proportion of amidated to total gastrins did not increase after successful eradication.",
keywords = "Ammonium, Biopsy, Clinical trial, Gastrin, Gastrin processing, Helicobacter pylori, Progastrin, Regulation, Triple therapy, Urea",
author = "Graham, {D. Y.} and Go, {M. F.} and Lew, {G. M.} and Genta, {R. M.} and Rehfeld, {J. F.}",
year = "1993",
doi = "10.3109/00365529309098274",
language = "English (US)",
volume = "28",
pages = "690--694",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Helicobacter pylori infection and exaggerated gastrin release

T2 - Effects of inflammation and progastrin processing

AU - Graham, D. Y.

AU - Go, M. F.

AU - Lew, G. M.

AU - Genta, R. M.

AU - Rehfeld, J. F.

PY - 1993

Y1 - 1993

N2 - Helicobacter pylori infection is associated with exaggerated gastrin release. We investigated whether this abnormality was due to the bacteria or the immune response. Fasting and meal-stimulated 'total' and amidated gastrin were measured in 10 H. pylori-infected volunteers before eradication therapy, after 2 and 14 days of therapy, and 4 weeks after completion of therapy. The exaggerated meal-stimulated gastrin concentration remained unchanged after 2 days of therapy, although the polymorphonuclear cell infiltrate and H. pylori bacteria were no longer evident. The expected fall in gastrin concentration after 14 days of therapy was associated with a reduction in the density of mucosal mononuclear cells, suggesting exaggerated gastrin release was related to chronic inflammation or to H. pylori or its products. The effect of H. pylori on normal progastrin processing was also assessed; 2 control groups were included: 10 H. pylori-uninfected volunteers and 13 patients with H. pylori peptic ulcers. There was a significant difference in the proportion of circulating gastrins that were biologically active amidated gastrins between ulcer patients and uninfected controls (56.7 ± 4% versus 33.8 ± 4% p < 0.001). The proportion of amidated to total gastrins did not increase after successful eradication.

AB - Helicobacter pylori infection is associated with exaggerated gastrin release. We investigated whether this abnormality was due to the bacteria or the immune response. Fasting and meal-stimulated 'total' and amidated gastrin were measured in 10 H. pylori-infected volunteers before eradication therapy, after 2 and 14 days of therapy, and 4 weeks after completion of therapy. The exaggerated meal-stimulated gastrin concentration remained unchanged after 2 days of therapy, although the polymorphonuclear cell infiltrate and H. pylori bacteria were no longer evident. The expected fall in gastrin concentration after 14 days of therapy was associated with a reduction in the density of mucosal mononuclear cells, suggesting exaggerated gastrin release was related to chronic inflammation or to H. pylori or its products. The effect of H. pylori on normal progastrin processing was also assessed; 2 control groups were included: 10 H. pylori-uninfected volunteers and 13 patients with H. pylori peptic ulcers. There was a significant difference in the proportion of circulating gastrins that were biologically active amidated gastrins between ulcer patients and uninfected controls (56.7 ± 4% versus 33.8 ± 4% p < 0.001). The proportion of amidated to total gastrins did not increase after successful eradication.

KW - Ammonium

KW - Biopsy

KW - Clinical trial

KW - Gastrin

KW - Gastrin processing

KW - Helicobacter pylori

KW - Progastrin

KW - Regulation

KW - Triple therapy

KW - Urea

UR - http://www.scopus.com/inward/record.url?scp=0027184398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027184398&partnerID=8YFLogxK

U2 - 10.3109/00365529309098274

DO - 10.3109/00365529309098274

M3 - Article

C2 - 8210984

AN - SCOPUS:0027184398

VL - 28

SP - 690

EP - 694

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 8

ER -